ImmuPharma Realizes £1.5 Million from Share Sale
Company Announcements

ImmuPharma Realizes £1.5 Million from Share Sale

ImmuPharma (GB:IMM) has released an update.

ImmuPharma PLC, the specialist drug discovery and development company, has successfully sold its entire stake of approximately 9.9 million shares in Incanthera plc, generating gross proceeds of around £1.5 million. Despite this sale, ImmuPharma still holds about 7.3 million warrants in Incanthera, exercisable until 6 September 2024. ImmuPharma is known for developing peptide-based therapeutics, focusing on treatments for autoimmune diseases and anti-infectives, with its leading program P140 targeting Lupus and CIDP.

For further insights into GB:IMM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskImmuPharma Extends Incanthera Warrants to 2025
TipRanks UK Auto-Generated NewsdeskImmuPharma Shows Strong Progress and Reduced Losses
TipRanks UK Auto-Generated NewsdeskImmuPharma Share Ownership Shift Notified
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App